Oliver Luxxe Assets’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-835
Closed -$455K 221
2024
Q4
$455K Buy
835
+415
+99% +$236K 0.04% 192
2024
Q3
$246K Sell
420
-88
-17% -$49.8K 0.04% 176
2024
Q2
$259K Buy
508
+1
+0.2% +$490 0.05% 171
2024
Q1
$251K Sell
507
-13
-3% -$6.61K 0.05% 165
2023
Q4
$274K Sell
520
-65
-11% -$34.7K 0.06% 158
2023
Q3
$295K Hold
585
0.08% 150
2023
Q2
$281K Hold
585
0.07% 152
2023
Q1
$276K Buy
585
+5
+0.9% +$2.41K 0.07% 156
2022
Q4
$308K Sell
580
-5
-0.9% -$2.65K 0.09% 153
2022
Q3
$295K Sell
585
-80
-12% -$42.1K 0.09% 156
2022
Q2
$341K Buy
665
+20
+3% +$10K 0.1% 154
2022
Q1
$329K Buy
645
+23
+4% +$11.1K 0.08% 169
2021
Q4
$312K Sell
622
-1
-0.2% -$453 0.08% 174
2021
Q3
$243K Sell
623
-42
-6% -$17.4K 0.07% 185
2021
Q2
$266K Buy
665
+75
+13% +$29.9K 0.07% 167
2021
Q1
$220K Hold
590
0.07% 166
2020
Q4
$213K Buy
+590
New +$198K 0.07% 158
2020
Q1
Sell
-809
Closed -$238K 137
2019
Q4
$238K Buy
+809
New +$212K 0.12% 115
2018
Q4
Sell
-750
Closed -$201K 117
2018
Q3
$201K Buy
+750
New +$195K 0.11% 105

Other funds holding UNH

Oliver Luxxe Assets's UNH Position: Q1 2025 in Review

Oliver Luxxe Assets sold out of UnitedHealth (UNH) in Q1 2025, closing a stake of 835 shares — an estimated $455K sold.

Oliver Luxxe Assets first reported a position in UNH in Q3 2018 and held it in 19 quarters. The position peaked at $455K in Q4 2024. 3,602 funds tracked by Wall St. Rank hold UNH as of Q1 2025.

  • Oliver Luxxe Assets reported no remaining UnitedHealth position as of Q1 2025 after selling out during the quarter.
  • Oliver Luxxe Assets sold 835 UnitedHealth shares in Q1 2025, an estimated $455K.
  • Oliver Luxxe Assets first reported a position in UnitedHealth in Q3 2018 and held it in 19 quarters.
  • Oliver Luxxe Assets's UnitedHealth position peaked at $455K in Q4 2024.
  • 3,602 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2025.

Based on Oliver Luxxe Assets's 13F filing for Q1 2025, filed 14 May 2025.